{"title": "Older patients with Crohn's disease benefit from new medications", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/chronic_illness.xml", "value": "Older patients with Crohn's disease benefit from new medications"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190320102036.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190320102036.htm", "summary": "Combining medications that suppress the immune system has been successful in treating young patients with Crohn's disease, but some physicians have been reluctant to use this strategy in older patients because of concerns about safety. Now a new study indicates that older patients can be safely and effectively treated with such combined immunosuppression as well.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/chronic_illness.xml", "value": "Combining medications that suppress the immune system has been successful in treating young patients with Crohn's disease, but some physicians have been reluctant to use this strategy in older patients because of concerns about safety. Now a new study indicates that older patients can be safely and effectively treated with such combined immunosuppression as well."}, "published": "Wed, 20 Mar 2019 10:20:36 EDT", "published_parsed": [2019, 3, 20, 14, 20, 36, 2, 79, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190320102036.htm", "guidislink": false}